Yongcheol Ahn

Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

Kwonoh Park, Jae‐Lyun Lee, Inkeun Park et al. · Medical Oncology · 2012 · 44 citations

Medicine, Oncology, Pharmacology +17

Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma

Seongjoon Park, Jae‐Lyun Lee, Inkeun Park et al. · Chemotherapy · 2012 · 34 citations

Medicine, Oncology, Pharmacology +14

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features

Jae‐Lyun Lee, Inkeun Park, Kwonoh Park et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14